Tata Consultancy Services (TCS)

Similar documents
Tata Consultancy Services (TCS)

Tata Consultancy Services (TCS)

Wipro ACCUMULATE. Performance Highlights CMP. `539 Target Price `582. 1QFY2017 Result Update IT. Investment Period 12 Months

Tech Mahindra ACCUMLATE. Performance Highlights `495 `526. CMP Target Price. 2QFY2018 Result Update IT

Wipro BUY. Performance Highlights. CMP Target Price `539 `680. 4QFY2016 Result Update IT. 3-year price chart. Key financials (Consolidated, IFRS)

Amber Enterprises India Ltd

Tech Mahindra ACCUMULATE. Performance Highlights. CMP Target Price `659 `693. 3QFY2012 Result Update IT. Key financials (Consolidated, Indian GAAP)

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months

Rallis India NEUTRAL. Performance Highlights CMP. `237 Target Price - 1QFY2018 Result Update Agrichemical. Investment Period - 3-year price chart

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

Parag Milk Foods BUY. Performance Update CMP. `256 Target Price `330. 2QFY2019 Result Update Dairy Products. Investment Period 12 Months

Rallis India SELL. Performance Highlights. `231 Target Price 189 CMP. 2QFY2018 Result Update Agrichemical. Investment Period 12 months

Inox Wind BUY. Performance Highlights. CMP Target Price `390 `505. 2QFY2016 Result Update Capital Goods. 3 year price chart

Mahindra & Mahindra Ltd.

Mahindra & Mahindra Ltd.

Hindustan Media Ventures

Rallis India NEUTRAL. Performance Highlights CMP. `242 Target Price - 4QFY2017 Result Update Agrichemical. Investment Period - 3-year price chart

Rallis India NEUTRAL. Performance Highlights CMP. `215 Target Price - 3QFY2017 Result Update Agrichemical. Investment Period - 3-year price chart

Tata Steel NEUTRAL. Performance Highlights CMP. `226 Target Price - 2QFY2016 Result Update Steel. Investment Period - 3-year price chart

TV Today Network BUY. Performance Update CMP. `323 Target Price `498. 3QFY2019 Result Update Media. Investment Period 12 Months

Tech Mahindra ACCUMULATE. Performance Highlights CMP. `955 Target Price `1,070. 2QFY2013 Result Update IT. Investment Period 12 months

Maruti Suzuki India BUY. Performance Update. CMP `9,315 Target Price `10,820. 1QFY2019 Result Update Automobile. Historical share price chart

Parag Milk Foods BUY. Performance Update CMP. `324 Target Price `410. 1QFY2019 Result Update Dairy Products. Investment Period 12 Months

GMM Pfaudler Limited BUY. Performance Update CMP. `945 Target Price ` QFY2019 Result Update Industrial Machinery. Investment Period 12 Months

Coal India ACCUMULATE. Performance Highlights CMP. `338 Target Price `380. Outlook and valuation. 2QFY2016 Result Update Mining

Blue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart.

Inox Wind BUY. Performance Highlights. CMP Target Price `242 `286. 4QFY2016 Result Update Capital Goods. 3 year price chart

KPIT Cummins ACCUMULATE. Performance Highlights CMP. `121 Target Price `132. 2QFY2013 Result Update IT. Investment Period 12 Months

Sanofi India NEUTRAL. Performance Highlights. CMP `4,301 Target Price - 4QCY2016 Result Update Pharmaceutical. Investment Period - 3-year price chart

Music Broadcast BUY. Performance Update. CMP Target Price `329 `475. 2QFY2019 Result Update Media. Historical share price chart.

Dr. Reddy s Laboratories

Bata India BUY. Performance Update. CMP Target Price `842. 1QFY2019 Result Update Footwear. Historical share price chart.

Cadila Healthcare NEUTRAL. Performance Highlights CMP. `495 Target Price - 4QFY2017 Result Update Pharmaceutical.

Procter & Gamble Hygiene & Health Care

Music Broadcast BUY. Performance Update. CMP Target Price `293 `475. 3QFY2019 Result Update Media. Stock Info Sector Market Cap (Rs cr) Media

Bata India BUY. Performance Update. CMP `1,008 Target Price `1,243. 2QFY2019 Result Update Footwear. Historical share price chart.

Quick take. Ruchira Papers Ltd. BUY. Creating value through paper. Target Price. Investment Period 12 Months. 3 year daily price chart.

Maruti Suzuki India BUY. Performance Update. CMP `6,705 Target Price `8,552. 2QFY2019 Result Update Automobile. Historical share price chart

TV Today Network BUY. Performance Update. CMP Target Price `315 `385. 2QFY2017 Result Update Media. Historical share price chart.

Asian Granito BUY. Performance Highlights CMP. `270 Target Price `351. Outlook and valuation. 3QFY2017 Result Update Ceramics

Amara Raja Batteries BUY. Performance Highlights. CMP `1,010 Target Price `1,167. 2QFY2017 Result Update Auto Ancillary. 3-year price chart

Greenply Industries BUY. The plywood maker for growing India. Target Price. Initiating Coverage Plywood. 3-year price chart.

Sanofi India NEUTRAL. Performance Highlights. CMP `4,007 Target Price - 2QCY2017 Result Update Pharmaceutical. 3-year price chart.

Sanofi India ACCUMULATE. Performance Highlights. CMP `4,410 Target Price `4,738. 1QCY2016 Result Update Pharmaceutical. 3-year price chart

Sanofi India NEUTRAL. Performance Highlights. CMP `4,007 Target Price - 3QCY2017 Result Update Pharmaceutical. Investment Period 12 months

Ambuja Cements ACCUMULATE. Performance Highlights. CMP Target Price `207 `233. 3QCY2015 Result Update Cement. Quarterly results (Standalone)

ACC BUY. Performance Highlights. CMP `1,397 Target Price `1,630. 3QCY2015 Result Update Cement

Hero MotoCorp ACCUMULATE. Performance Highlights. CMP `3,226 Target Price `3,466. 3QFY2017 Result Update Automobile. 3-year price chart

Goodyear India BUY. Company Update. CMP Target Price `515 `631. Company Update Tyres. 3-year Daily Price Chart. Key Financials

CCL Products BUY. Brewing Steadily. CMP Target Price `300 `360. Initiating Coverage Coffee. January 4, year price chart

Lupin BUY. Performance Highlights. CMP `1,493 Target Price `1,809. 2QFY2017 Result Update Pharmaceutical. 3-year price chart

Cadila Healthcare NEUTRAL. Performance Highlights CMP. `440 Target Price. 3QFY2017 Result Update Pharmaceutical. Investment Period -

Reliance Communication

Cadila Healthcare NEUTRAL. Performance Highlights CMP. `390 Target Price - 2QFY2017 Result Update Pharmaceutical. Investment Period -

GAIL India NEUTRAL. Performance Highlights CMP. `363 Target Price - 2QFY2013 Result Update Oil & Gas. Investment Period -

NIIT BUY. Performance Highlights CMP. `55 Target Price `68. 4QFY2011 Result Update Education. Investment Period 12 Months

KPIT Cummins BUY. Performance Highlights CMP. `105 Target Price `135. 4QFY2013 Result Update IT. Investment Period 12 Months

Federal Bank BUY. Performance Highlights. Target Price. 1QFY2018 Result Update Banking. Stock Info Sector

Quick take. VIP Industries BUY. Travelling smart on the luggage track. CMP Target Price `153 ` year daily price chart

LIC Housing Finance BUY. Performance Highlights. CMP Target Price `532 `630. 3QFY2017 Result Update HFC. 3-Year Daily Price Chart

Jindal Steel & Power BUY. CMP Target Price `200 `320. 1QFY2019 Result Update Steel & Power. Performance Update

Dr Reddy s Laboratories

LT Foods BUY. Performance Update. CMP Target Price `92 `128. 3QFY2018 Result Update Media February 12, 2018

ICICI Bank BUY. Performance Highlights. CMP Target Price `328 `416. 3QFY2018 Result Update Banking. 3-year price chart. Key financials (Standalone)

HDFC Bank BUY. Performance Highlights. CMP `2,145 Target Price `2,500. Q3FY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

Cipla REDUCE. Performance Highlights. CMP Target Price `564 `490. 2QFY2017 Result Update Pharmaceutical. Investment Period - 3-Year Daily Price Chart

Goodyear India ACCUMULATE. Performance Highlights. CMP Target Price `326 `374. 1QCY2012 Result Update Tyres. Key financials

LT Foods BUY. Performance Update. CMP Target Price `76 `128. 4QFY2018 Result Update Media

KEI Industries BUY. Performance Update. CMP Target Price `433 `508. 4QFY2018 Result Update Cable. Historical share price chart.

Lupin 1QFY2018 Result Update

Mahindra & Mahindra Ltd.

Aurobindo Pharma ACCUMULATE. Performance Highlights. `780 Target Price CMP `855. 2QFY2019 Result Update Pharmaceutical. Investment Period 12 months

ICICI Bank BUY. Performance Highlights. CMP Target Price `343 `460. Q3FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

HDFC Bank BUY. Operating performance strong; improved NIM. CMP `2,268 Target Price `2,500. Q4FY2019 Result Update Banking. 3-year price chart

KEI Industries BUY. Performance Update. Target Price. 3QFY2018 Result Update Cable. Historical share price chart. Key Financials

Dr. Reddy s Laboratories

Sun Pharma BUY. Performance Highlights. `683 Target Price `847 CMP. 2QFY2017 Result Update Pharmaceutical. Investment Period 12 months

Transport Corporation of India

FY2017 FY2018E FY2019E

Matrimony.com Ltd BUY. A complete package from matchmaking to wedding. Target Price. Initiating Coverage Internet Software & Services

Aurobindo Pharma BUY. Performance Highlights. `708 Target Price CMP `823. 2QFY2018 Result Update Pharmaceutical. Investment Period 12 months

TVS Motor Company BUY. Performance Highlights. CMP Target Price `39 `45. 2QFY2013 Result Update Automobile. Quarterly highlights (Standalone)

Axis Bank BUY. CMP Target Price `620 `750. Update Bank. Earnings to normalize with stabilizing credit costs. 3-year price chart.

MRF BUY. Performance Highlights. CMP `9,407 Target Price `11,343. Company Update Automobile. Key financials

Cadila Healthcare ACCUMULATE. Performance Highlights. CMP 860 Target Price QFY2013 Result Update Pharmaceutical. Key financials (Consolidated)

Blue Star Ltd BUY. Performance Update. CMP Target Price `754 `867. 4QFY2018 Result Update Cons. Durable. 3-year price chart.

Aurobindo Pharma BUY. Performance Highlights CMP. `580 Target Price `823. 4QFY2017 Result Update Pharmaceutical. Investment Period 12 months

HDFC Bank BUY. Performance Highlights. CMP `1,965 Target Price `2,350. Q2FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

Sun Pharma BUY. Performance Highlights. `783 Target Price `944 CMP. 1QFY2017 Result Update Pharmaceutical. Investment Period 12 months

TV Today Network BUY. Go with the market leader. CMP Target Price `297 `363. Initiating Coverage Media. 3-year price chart

CCL Products BUY. Performance Update. CMP Target Price `278 `360. 3QFY2018 Result Update Coffee. Historical share price chart.

ACC NEUTRAL. Performance Highlights. CMP `1,261 Target Price - 4QCY2012 Result Update Cement. Quarterly results (Standalone) Investment Period -

Hero MotoCorp ACCUMULATE. Performance Highlights. CMP `3,718 Target Price `4,130. 1QFY2018 Result Update Automobile. 3-year price chart

SpiceJet BUY. Performance Highlights CMP. `32 Target Price `43. 1QFY2013 Result Update Airlines. Investment Period 12 Months.

United Phosphorus ACCUMULATE. Performance Highlights `754. CMP Target Price. 2QFY2018 Result Update Agrichemical. 3-year price chart

ICICI Bank BUY. Performance Highlights. CMP Target Price `307 `411. 1QFY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

Matrimony.com Ltd BUY. Performance Update. Target Price `1,016. 4QFY2018 Result Update Cable. Historical share price chart.

Aurobindo Pharma BUY. Performance Highlights CMP. `686 Target Price `877. 3QFY2017 Result Update Pharmaceutical. Investment Period 12 months

Graphite India BUY. Performance Highlights CMP. `93 Target Price `124. 4QFY2012 Result Update Capital Goods. Investment Period 12 Months

HFC NEUTRAL. Performance Highlights CMP. `678 Target Price - 1QFY2013 Result Update HFC. Investment Period - Key financials

Transcription:

Oct-12 Apr-13 Oct-13 Apr-14 Oct-14 Apr-15 Oct-15 Apr-16 Oct-16 Apr-17 Oct-17 2QFY2018 Result Update IT October 25, 2017 Tata Consultancy Services (TCS) Performance highlights (` cr) 2QFY18 1QFY18 % chg (qoq) 2QFY17 % chg (yoy) Net revenue 30,541 29,584 3.2 29,284 4.3 Adj. EBITDA 7,065 7,413 (4.7) 7,965 (11.4) Adj. EBITDA margin (%) 26.8 25.1 171bp 27.2 (94.1)bp Adj. PAT 6,460 5,950 8.6 6,603 (2.2) For 2QFY2018, TCS posted above expectation results on the EBIT and net profit fronts. The company posted 3.2% sequential growth in USD revenues to US$4,739mn v/s. US$4,738mn expected, mostly driven by volume (3.2% qoq growth). In Constant Currency (CC) terms, the company posted a 1.7% qoq growth. EBIT margins came in at 25.1% v/s. 24.1% expected, posting a qoq expansion of 171bps. Consequently, PAT came in at `6,460cr v/s. `6,314cr expected, growing 8.6% qoq. We maintain our Neutral rating. Quarterly highlights: Company posted 3.2% sequential growth in USD revenues to US$4,739mn v/s. US$4,738mn expected, mostly volume led (3.2% qoq growth). In CC terms, the company posted a 1.7% qoq growth. Geographically, performance was mixed within USA (North America posted 1.4% vs Latin America s 5.7% qoq CC), Europe (UK posted a 2.5% qoq CC growth vs 5.3% for Continental Europe), and Asia Pacific (posted a 3.0% qoq CC growth). In terms of verticals, BFSI, Communication & Media, Manufacturing, Life Sciences & healthcare, and Energy & Utilities posted qoq CC growth of 1.9%, 1.4%, 1.9%, 3.6%, and 7.2% respectively. Retail & CPG growth dipped marginally by 0.9% qoq CC. In profitability terms, the EBIT margins came in at 25.1% v/s. 24.1% expected, posting a qoq expansion of 171bps. Consequently, PAT came in at `6,460cr v/s. `6,314cr expected, a growth of 8.6% qoq. Outlook and valuation: The Company has been cautiously optimistic regarding its outlook for FY2018, with key verticals like BFSI and Hi-Tech expected to post a recovery. We expect TCS to post revenue CAGR of 8.5% and 6.8% in USD & INR terms respectively over FY2017-19E. Hence, maintain our Neutral recommendation. Key financials (Consolidated, IFRS) Y/E March (` cr) FY2016 FY2017 FY2018E FY2019E Net sales 1,08,646 1,17,966 1,23,384 1,34,488 % chg 14.8 8.6 4.6 9.0 Net profit 24,215 26,289 26,063 28,116 % chg 11.6 8.6 (0.9) 7.9 EBITDA margin (%) 28.3 27.5 26.1 26.1 EPS (`) 123.7 134.3 133.2 143.7 P/E (x) 20.9 19.3 19.4 18.0 P/BV (x) 6.9 5.7 5.4 5.0 RoE (%) 33.1 29.8 27.6 27.8 RoCE (%) 31.6 28.8 26.6 27.0 EV/Sales (x) 4.3 3.8 3.7 3.3 EV/EBITDA (x) 15.1 13.8 14.0 12.6 ; Note: CMP as of October 23, 2017 NEUTRAL CMP `2,586 Target Price - Investment Period Stock Info Sector Bloomberg Code Shareholding Pattern (%) 12 Months Market Cap (` cr) 4,95,025 Net Debt (` cr) -45,288 Beta 0.5 52 Week High / Low 2,834/2,055 Avg. Daily Volume 52,445 Face Value (`) 1 BSE Sensex 32,507 Nifty 10,185 Reuters Code Promoters 73.6 MF / Banks / Indian Fls 5.7 FII / NRIs / OCBs 16.8 Indian Public / Others 4.0 Abs.(%) 3m 1yr 3yr Sensex 0.8 15.4 21.1 TCS 2.1 6.5 4.9 3-Year Daily Price Chart 3,000 2,000 1,000 0 Sarabjit kour Nangra +91 22 3935 7800 Ext: 6806 sarabjit @angelbroking.com IT TCS.BO TCS@IN Please refer to important disclosures at the end of this report 1

Exhibit 1: 2QFY2018 performance (Consolidated, IFRS) (` cr) 2QFY2018 1QFY2018 % chg (qoq) 2QFY2017 % chg (yoy) 1HFY2018 1HFY2017 % chg(yoy) Net revenue 30,541 29,584 3.2 29,284 4.3 60,125 58,589 2.6 Cost of revenue 17,097 16,792 1.8 16,038 6.6 33,889 32,350 4.8 Gross profit 13,444 12,792 5.1 13,246 1.5 26,236 26,239 (0.0) SG&A expense 5,270 5,379 (2.0) 5,133 2.7 10,649 10,289 3.5 EBITDA 8,174 7,413 10.3 8,113 0.8 15,587 15,950 (2.3) Dep. and amortisation 514 499 3.0 496 3.6 1,013 986 2.7 EBIT 7,660 6,914 10.8 7,617 0.6 14,574 14,964 (2.6) Other income 812 932 (12.9) 1,052 (22.8) 1,744 2,015 (13.4) PBT 8,472 7,846 8.0 8,669 (2.3) 16,318 16,979 (3.9) Income tax 2,012 1,896 6.1 2,066 (2.6) 3,908 4,058 (3.7) PAT 6,460 5,950 8.6 6,603 (2.2) 12,410 12,921 (4.0) Earnings in affiliates - - - - - - - Minority interest - - - - - - Reported PAT 6,460 5,950 8.6 6,603 (2.2) 12,410 12,921 (4.0) Adj. PAT 6,460 5,950 8.6 6,603 (2.2) 12,410 12,921 (4.0) EPS 33.7 30.4 8.6 33.4 (2.2) 64.0 65.5 (4.0) Gross margin (%) 44.0 43.2 78bp 45.2 (121)bp 43.6 44.8 (115)bp EBITDA margin (%) 26.8 25.1 171bp 27.7 (94)bp 25.9 27.2 (130)bp EBIT margin (%) 25.1 23.4 171bp 26.0 (93)bp 24.2 25.5 (130)bp Exhibit 2: Actual v/s Angel estimates (` cr) Actual Estimate Var. (%) Net revenue 30,541 30,465 0.3 EBIT margin (%) 25.1 24.1 100bps Adj. PAT 6,460 6,314 2.3 Numbers just in-line with expectations The company posted 3.2% sequential growth in USD revenues to US$4,739mn v/s. US$4,738mn expected, mostly volume driven (3.2% qoq growth). Constant Currency terms, the company posted a 1.7% qoq growth. In Rupee terms, revenues are expected to come in at `30,541cr v/s. `30,465cr expected, up 3.2% qoq. In terms of verticals, on CC basis, the growth registered by the company in respective segments was, BFSI (1.9% qoq), Retail & CPG (-0.9% qoq), Communication & Media (1.4% qoq), Manufacturing (1.9% qoq), Life Sciences & Healthcare (3.6% qoq), Hi-Tech (3.4% qoq), Energy Utilities (7.2% qoq), Travel & Hospitality (8.0% qoq). In terms of geography, on CC basis, qoq growth was North America (1.4%), Latin America (5.7%), UK (2.5%), Continental Europe (5.3%), India (-6.8%), Asia Pacific (3.0%), MEA (1.0%). October 23, 2017 2

Exhibit 3: Trend in volume and revenue growth (qoq) Exhibit 4: Revenue drivers for 2QFY2018 Overall growth has been bogged down by relative weakness in the verticals of BFSI and Retail, similar to 1QFY2018. In BFSI, TCS will assess visibility in the next quarter by when spending is likely to revive. In Retail, TCS believes it has now bottomed out and should see improvement going forward. Revenue from Digital grew by 5.9% qoq, and it now constitutes to 19.7% of total revenue. Exhibit 5: Revenue growth (Industry wise on CC basis) % to revenue % chg (CC qoq) % chg (yoy) BFSI 33.0 1.9 4.7 Manufacturing 7.5 1.9 9.6 Communication & Media 7.3 1.4 9.5 Life sciences and healthcare 7.2 3.6 10.3 Retail and CPG 11.9 (0.9) (1.4) Transportation & Hospitality 3.8 3.4 23.2 Energy and utilities 4.2 7.2 22.7 Technology & Services 8.1 3.4 10.1 Regional Markets & Others 17.0 (0.6) 6.9 October 23, 2017 3

Geography wise growth in INR sales in key geographies was as follows: USA (1.4% qoq on CC basis), Latin America (5.7% qoq on CC basis), UK (2.5% qoq on CC basis), India (-6.8% qoq on CC basis), and MEA (1.0% qoq on CC basis). However, Continental Europe and Asia Pacific posted growth of 5.3% qoq and 3.0% qoq on CC basis respectively. Exhibit 6: Revenue growth (Geography wise in INR terms) % of revenue % chg (CC qoq) % chg (yoy) U.S. 51.9 1.4 3.6 Latin America 2.2 5.7 13.6 U.K. 14.0 2.5 9.2 Continental Europe 13.4 5.3 18.2 India 6.3 (6.8) 14.3 Asia Pacific 9.8 3.0 4.1 MEA 2.4 1.0 7.6 Attrition rate dips In 2QFY2018, TCS witnessed a gross addition of 15,868 employees and net addition of 3,404 employees, taking its total employee base to 3,89,213. During the quarter, the attrition rate (last twelve month [LTM] basis) for the company increased to 11.3% from 12.4% in 1QFY2018. Exhibit 7: Hiring and attrition trend Particulars 2QFY17 3QFY17 4QFY17 1QFY18 2QFY18 Gross addition 22,665 18,362 20,093 11,202 15,868 Net addition 9,440 6,978 8,726 (1,414) 3,404 Total employee base 3,71,519 3,78,497 3,87,223 3,85,809 3,89,213 Attrition (%) - LTM basis 12.9 12.2 11.5 12.4 11.3 Margin expands On the operating front, the company reported EBITDA and EBIT margins at 26.8% and 25.1%, i.e. an expansion of 171bps and 171bps qoq respectively. While 50bps of this was on account of favorable ` movement against the GBP and EUR, 120bps was led by an improvement in operational efficiencies and cost rationalization. October 23, 2017 4

Exhibit 8: Adj. Margin profile Client metrics The client pyramid during the quarter witnessed a qualitative improvement with client additions seen in the higher revenue brackets. The clients in US$100mn+ revenue band increased by 1 and in US$50mn+ revenue band increased by 5. Exhibit 9: Client pyramid 2QFY17 3QFY17 4QFY17 1QFY18 2QFY18 US$1mn 5mn 410 426 438 441 463 US$5mn 10mn 154 154 149 142 142 US$10mn 20mn 110 114 120 132 132 US$20mn 50mn 107 106 106 105 105 US$50mn 100mn 42 46 49 49 54 US$100mn plus 36 34 35 36 37 October 23, 2017 5

Investment Argument Guidance Stability visible: While management has not given any guidance for FY2018, however it expects its key verticals like BFSI, Communications and Hi-Tech to stabilize as we move. Digital also continues to see a good traction, constituting 19.7% of total revenue, and having grown by 5.9% qoq CC and 31% yoy. Overall the volume growth has been robust according to us for the 1HFY2018, in spite of the challenges. On EBIT front, the company expects to manage its margins in 26-28% range over medium term. For FY2018, we have estimated the EBIT margins of 24.3% V/s 24.2% in 1HFY2018. On sales front, we expect the company to post a US$ revenue CAGR of 8.5% over FY2017-19E. Management Reggie: With Mr. Natarajan Chandrasekaran being the Chairman of Tata Sons since February 21, 2017, CFO Mr. Rajesh Gopinathan has taken charge as the CEO of the company. He started his professional career with TCS in 2001 and was appointed as the CFO in February 2013. TCS also announced N G Subramanian as the COO of the company. Thus, the new targets under the new CEO will have a bearing on the performance of the company. Outlook and valuation Over FY2017-19E, we expect TCS to post revenue CAGR of 8.5% and 6.8% in USD and INR terms, respectively. The company highlighted that it stands comfortable in sustaining the EBIT margin in the range of 26-28%. On the EBIT and PAT fronts, we expect the company to post 3.8% and 3.4% CAGR over FY2017-19E respectively. The stock is trading at 18.0x FY2019E EPS of `143.7. We maintain our Neutral recommendation. Exhibit 10: Key assumptions FY2018E FY2019E Revenue growth (USD) 8.0 9.0 USD-INR rate (realized) 65.0 65.0 Revenue growth (`) 4.6 9.0 EBITDA margin (%) 26.1 26.1 Tax rate (%) 23.5 23.5 EPS growth (%) (0.9) 7.9 October 23, 2017 6

Jan-09 Jun-09 Nov-09 Apr-10 Sep-10 Feb-11 Jul-11 Dec-11 May-12 Oct-12 Mar-13 Aug-13 Jan-14 Jun-14 Nov-14 Apr-15 Sep-15 Feb-16 Jul-16 Dec-16 May-17 Oct-17 (`) TCS 2QFY2018 Result Update Exhibit 11: One-year forward PE chart 4,000 3,500 3,000 2,500 2,000 1,500 1,000 500 0 Price 25x 21x 16x 11x 6x Exhibit 12: Recommendation summary Company Reco CMP Tgt. price Upside FY2019E FY2019E FY2017-19E FY2019E FY2019E (`) (`) (%) EBITDA (%) P/E (x) EPS CAGR (%) EV/Sales (x) RoE (%) HCL Tech Accumulate 935 1,014 8.4 20.9 13.2 6.2 1.8 20.6 Infosys Under Review 940 - - 26.0 13.4 5.3 2.1 19.6 TCS Neutral 2,586 - - 26.1 18.0 3.4 3.3 27.8 Tech Mahindra Buy 462 533 15.4 15.0 12.1 8.6 1.3 16.3 Wipro Neutral 297 - - 20.3 15.2 4.4 1.5 13.4 October 23, 2017 7

Company background TCS is Asia's largest IT services provider and is amongst the top 10 technology firms in the world. The company has a global footprint with an employee base of over 3lakh professionals, offering services to more than 1,000 clients across various industry segments. The company has one of the widest portfolios of service offerings, spanning across the entire IT service value chain from traditional application development and maintenance to consulting and package implementation to products and platforms. October 23, 2017 8

Profit & Loss statement (Consolidated, IFRS) Y/E March (` cr) FY2015 FY2016 FY2017 FY2018E FY2019E Net sales 94,648 1,08,646 1,17,966 1,23,384 1,34,488 Cost of revenue 50,599 58,952 64,764 68,478 74,641 Gross profit 44,049 49,695 53,202 54,906 59,847 % of net sales 46.5 45.7 45.1 44.5 44.5 SGA expenses 17,353 18,956 20,755 22,703 24,746 % of net sales 18.3 17.4 17.6 18.4 18.4 EBITDA 26,696 30,738 32,447 32,203 35,101 % of net sales 28.2 28.3 27.5 26.1 26.1 Dep. and amortization 1272 1948 2123 2221 2421 % of net sales 1.3 1.8 1.8 1.8 1.8 EBIT 25,424 28,790 30,324 29,982 32,681 % of net sales 26.9 26.5 25.7 24.3 24.3 Other income, net 3140 3050 4189 4189 4189 Profit before tax 28,564 31,840 34,513 34,171 36,870 Provision for tax 6,083 7,503 8,156 8,030 8,664 % of PBT 21.3 23.6 23.6 23.5 23.5 PAT 22,481 24,338 26,357 26,141 28,205 Minority interest 205 123 68 78 89 Extra-ordinary (Exp.)/ Inc. -2627.9 Reported PAT 19,648 24,215 26,289 26,063 28,116 Adj. PAT 21,696 24,215 26,289 26,063 28,116 Diluted EPS (`) 110.9 123.7 134.3 133.2 143.7 October 23, 2017 9

Balance sheet (Consolidated, IFRS) Y/E March (` cr) FY2015 FY2016 FY2017 FY2018E FY2019E Assets Cash and cash equivalents 1,862 1,862 3,597.0 3,477.2 3,356.1 Other current financial assets 16,383 4,833 - - - Accounts receivable 20,440 24,073 22,684 31,694 31,695 Unbilled revenues 3,827 3,992 5,351 5,348 5,349 Other current assets 6,414 5,975 7,258 7,258 7,258 Property and equipment 11,572 11,790 11,741 12,741 13,741 Intangible assets and goodwill 3,931 3,946 3,768 3,768 3,768 Investments 9,619 22,822 41,980 39,267 46,761 Other non current assets 906 11,919 8,974 8,974 8,974 Total assets 74,954 91,212 1,05,353 1,12,527 1,20,901 Liabilities Current liabilities 14,428 15,407 14,294 14,806 16,139 Short term borrowings 243 162 218 218 218 Redeemable preference shares - (0) - 1 2 Long term debt 114 83 71 71 71 Other non current liabilities 1,778 2,017 2,089 2,431 2,650 Minority interest 914 354 366 444 533 Shareholders funds 57,477 73,190 88,315 94,557 1,01,291 Total liabilities 74,954 91,212 1,05,353 1,12,527 1,20,901 October 23, 2017 10

Cash flow statement (Consolidated, IFRS) Y/E March (` cr) FY2015 FY2016 FY2017 FY2018E FY2019E Pre-tax profit from oper. 22,481 24,338 26,357 26,141 28,205 Depreciation 1,272 1,948 2,123 2,221 2,421 Exp. (deferred)/written off 160 174 - - - Pre tax cash from oper 23,913 26,460 28,480 28,362 30,626 Other inc./prior period ad 1,272 1,948 2,123 2,221 2,421 Net cash from operations 25,185 28,408 30,604 30,583 33,047 Tax 6,083 7,503 8,156 8,030 8,664 Cash profits 19,102 20,905 22,448 22,553 24,382 (Inc)/dec in acc. recv. (2,210) (3,633) 1,389 (9,010) (1) (Inc)/dec in unbilled rev. 179 (165) (1,359) 3 (1) (Inc)/dec in oth. current asst. (6,414) 439 (1,283) - - Inc/(dec) in current liab. (1,207) (218) 49 (1,000) (1,000) Net trade working capital (9,652) (3,577) (1,204) (10,007) (1,002) Cash flow from opert. actv. 9,450 17,328 21,243 12,546 23,380 (Inc)/dec in fixed assets (1,207) (218) 49 (1,000) (1,000) (Inc)/dec in investments (4,446) (1,653) (14,325) 2,713 (7,494) (Inc)/dec in intangible asst. (226) 16 (178) - - (Inc)/dec in non-cur.asst. (906) (11,013) 2,945 - - Cash flow from invt. actv. (6,786) (12,869) (11,509) 1,713 (8,494) Inc/(dec) in debt 61 (113) 44 - - Inc/(dec) in equity 223 (559) 12 78 89 Inc/(dec) in minority int. (19,923) (18,415) (19,993) (19,821) (21,382) Dividends 16,976 14,629 10,202 5,484 6,406 Cash flow from finan. actv. (2,664) (4,459) (9,735) (14,259) (14,887) Cash generated/(utilized) 393-1,735 (120) (121) Cash at start of the year 1,469 1,862 1,862 3,597 3,477 Cash at end of the year 1,862 1,862 3,597 3,477 3,356 October 23, 2017 11

Key ratios Y/E March FY2015 FY2016 FY2017 FY2018E FY2019E Valuation ratio(x) P/E (on FDEPS) 23.3 20.9 19.3 19.4 18.0 P/CEPS 24.2 19.4 17.8 17.9 16.6 P/BVPS 8.8 6.9 5.7 5.4 5.0 Dividend yield (%) 1.7 1.6 1.7 1.7 1.8 EV/Sales 4.9 4.3 3.8 3.7 3.3 EV/EBITDA 17.5 15.1 13.8 14.0 12.6 EV/Total assets 6.2 5.1 4.3 4.0 3.7 Per share data (`) EPS 110.9 123.7 134.3 133.2 143.7 Cash EPS 106.8 133.6 145.1 144.4 155.9 Dividend 43.5 40.2 43.6 43.2 46.6 Book value 294 374 451 483 518 Dupont analysis Tax retention ratio (PAT/PBT) 0.8 0.8 0.8 0.8 0.8 Cost of debt (PBT/EBIT) 1.1 1.1 1.1 1.1 1.1 EBIT margin (EBIT/Sales) 0.3 0.3 0.3 0.2 0.2 Asset turnover ratio (Sales/Assets) 1.3 1.2 1.1 1.1 1.1 Leverage ratio (Assets/Equity) 1.3 1.2 1.2 1.2 1.2 Operating ROE 39.1 33.3 29.8 27.6 27.8 Return ratios (%) RoCE (pre-tax) 33.9 31.6 28.8 26.6 27.0 Angel RoIC 54.0 46.7 50.7 43.0 46.2 RoE 34.2 33.1 29.8 27.6 27.8 Turnover ratios(x) Asset turnover (fixed assets) 8.2 9.2 10.0 9.7 9.8 Receivables days 79 81 70 94 86 October 23, 2017 12

Research Team Tel: 022-39357800 E-mail: research@angelbroking.com Website: www.angelbroking.com DISCLAIMER Angel Broking Private Limited (hereinafter referred to as Angel ) is a registered Member of National Stock Exchange of India Limited, Bombay Stock Exchange Limited and Metropolitan Stock Exchange Limited. It is also registered as a Depository Participant with CDSL and Portfolio Manager with SEBI. It also has registration with AMFI as a Mutual Fund Distributor. Angel Broking Private Limited is a registered entity with SEBI for Research Analyst in terms of SEBI (Research Analyst) Regulations, 2014 vide registration number INH000000164. Angel or its associates has not been debarred/ suspended by SEBI or any other regulatory authority for accessing /dealing in securities Market. Angel or its associates/analyst has not received any compensation / managed or co-managed public offering of securities of the company covered by Analyst during the past twelve months. This document is solely for the personal information of the recipient, and must not be singularly used as the basis of any investment decision. Nothing in this document should be construed as investment or financial advice. Each recipient of this document should make such investigations as they deem necessary to arrive at an independent evaluation of an investment in the securities of the companies referred to in this document (including the merits and risks involved), and should consult their own advisors to determine the merits and risks of such an investment. Reports based on technical and derivative analysis center on studying charts of a stock's price movement, outstanding positions and trading volume, as opposed to focusing on a company's fundamentals and, as such, may not match with a report on a company's fundamentals. Investors are advised to refer the Fundamental and Technical Research Reports available on our website to evaluate the contrary view, if any. The information in this document has been printed on the basis of publicly available information, internal data and other reliable sources believed to be true, but we do not represent that it is accurate or complete and it should not be relied on as such, as this document is for general guidance only. Angel Broking Pvt. Limited or any of its affiliates/ group companies shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. Angel Broking Pvt. Limited has not independently verified all the information contained within this document. Accordingly, we cannot testify, nor make any representation or warranty, express or implied, to the accuracy, contents or data contained within this document. While Angel Broking Pvt. Limited endeavors to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or other reasons that prevent us from doing so. This document is being supplied to you solely for your information, and its contents, information or data may not be reproduced, redistributed or passed on, directly or indirectly. Neither Angel Broking Pvt. Limited, nor its directors, employees or affiliates shall be liable for any loss or damage that may arise from or in connection with the use of this information. Disclosure of Interest Statement TCS 1. Financial interest of research analyst or Angel or his Associate or his relative No 2. Ownership of 1% or more of the stock by research analyst or Angel or associates or relatives No 3. Served as an officer, director or employee of the company covered under Research No 4. Broking relationship with company covered under Research No Ratings (Based on expected returns Buy (> 15%) Accumulate (5% to 15%) Neutral (-5 to 5%) over 12 months investment period): Reduce (-5% to -15%) Sell (< -15) October 23, 2017 13